Skip to main content
. 2021 Mar 2;185(2):315–322. doi: 10.1111/bjd.19810

Figure 1.

Figure 1

CONSORT flow diagram for the phase IIIa trial. aOne patient missed the day 15 visit but returned for day 29. b‘Other reasons’ indicated no or not enough effect of treatment. EC, exclusion criterion; EOS, end of study; FU, follow‐up; GPB, glycopyrronium bromide; IC, inclusion criterion.